Katherine Tarlock

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Rebecca Gardner, Francesco Ceppi, Julie Rivers et al. · Blood · 2019 · 279 citations · Full text

<i>CEBPA</i>-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang et al. · Blood · 2021 · 119 citations · Full text

Acute myeloid leukaemia (<scp>AML</scp>) with t(6;9)(p23;q34) is associated with poor outcome in childhood <scp>AML</scp> regardless of <i>FLT3</i>‐ITD status: a report from the Children's Oncology Group

Katherine Tarlock, Todd A. Alonzo, Pilar Palomo Moraleda et al. · British Journal of Haematology · 2014 · 67 citations · Full text

Sorafenib treatment following hematopoietic stem cell transplant in pediatric <i>FLT3</i>/ITD acute myeloid leukemia

Katherine Tarlock, Bill H. Chang, Todd M. Cooper et al. · Pediatric Blood & Cancer · 2015 · 64 citations

Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management

Rebecca Gardner, Kasey J. Leger, Colleen Annesley et al. · Blood · 2016 · 62 citations